J. B. Chemicals & Pharmaceuticals Limited has confirmed that all necessary formalities regarding the dematerialization of its securities have been completed. The company received verification from its Registrar and Share Transfer Agent, Datamatics Business Solutions Limited, ensuring that securities received for dematerialization during the quarter ending March 31, 2026, were duly processed, mutilated, and cancelled within the mandated 15-day window.
Share Dematerialization Process
J. B. Chemicals & Pharmaceuticals Limited has successfully concluded its mandatory verification process for equity shares received for dematerialization. This procedure, covering the period ending March 31, 2026, ensures that all relevant physical certificates were properly identified and nullified. By updating its records to reflect the depository as the registered owner, the company continues to uphold transparency and efficiency in its share management operations.
Operational Compliance
The company confirmed that the entire process was executed within the required 15-day timeline upon receipt of security certificates. This verification was conducted by Datamatics Business Solutions Limited, the official Registrar and Share Transfer Agent, ensuring accuracy and regulatory adherence for all stakeholders involved in the conversion process.
Source: BSE
